AETHLON MEDICAL, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AETHLON MEDICAL, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was -$4.49K.
- AETHLON MEDICAL, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was -$5.36K, a 100.29% decline year-over-year.
- AETHLON MEDICAL, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $1.84M.
- AETHLON MEDICAL, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-12-31 was -$9.37K.
- AETHLON MEDICAL, INC. stock issued during period, value, conversion of convertible securities for fiscal 2026 was -$10.91K.
- AETHLON MEDICAL, INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was -$18.93K.
- AETHLON MEDICAL, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was -$34.78K.
- AETHLON MEDICAL, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was -$12.49K, a 101.52% decline from fiscal 2022.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | -$4.49K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$10.91K 10-K · filed 2026-06-10 | |
| 2025-06-30 | -$5.36K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$18.93K 10-K · filed 2026-06-10 | |
| 2024-06-30 | $1.84M 10-Q · filed 2026-02-12 | |
| 2024-03-31 | -$34.78K 10-K · filed 2025-06-26 | |
| 2023-12-31 | -$9.37K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | -$9.84K 10-Q · filed 2024-02-14 | |
| 2023-06-30 | -$8.37K 10-Q · filed 2024-02-14 | |
| 2023-03-31 | -$12.49K 10-K · filed 2024-06-27 | |
| 2022-12-31 | -$1.89K 10-Q · filed 2024-02-14 | |
| 2022-09-30 | -$7.97K 10-Q · filed 2024-02-14 | |
| 2022-03-31 | $820.94K 10-K · filed 2023-06-28 | |
| 2021-06-30 | $820.94K 10-Q · filed 2023-02-13 | |
| 2020-12-31 | -$66.01K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | -$16.13K 10-Q · filed 2021-02-10 | |
| 2020-06-30 | -$24.25K 10-Q · filed 2021-02-10 | |
| 2020-03-31 | $3.81M 10-K · filed 2021-06-24 | |
| 2019-12-31 | -$6.77K 10-Q · filed 2021-02-10 | |
| 2019-09-30 | -$8.45K 10-Q · filed 2021-02-10 | |
| 2019-06-30 | -$23.77K 10-Q · filed 2021-02-10 | |
| 2019-03-31 | $292.93K 10-K · filed 2020-06-25 | |
| 2018-03-31 | $362.76K 10-K · filed 2019-07-01 | |
| 2017-03-31 | $144.72K 10-K · filed 2018-06-08 | |
| 2015-03-31 | $2.27M 10-K · filed 2016-06-29 | |
| 2014-03-31 | $726.78K 10-K · filed 2015-07-13 | |
| 2013-03-31 | $1.70M 10-K · filed 2013-07-15 | |
| 2012-03-31 | $2.06M 10-K · filed 2013-07-15 | |
| 2011-03-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-29 | $1.63M 10-K · filed 2012-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |